PASSAGE BIO, INC. Shareholders' Equity
PASSAGE BIO, INC. (PASG) had Shareholders' Equity of $4.46 million as of 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-03
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.46M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $11.75M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $18.75M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $31.12M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $4.46M S-4/A · filed 2026-09-03 |
| 2026-03-31 | $11.75M S-4/A · filed 2026-09-03 |
| 2025-12-31 | $18.75M S-4/A · filed 2026-09-03 |
| 2025-09-30 | $31.12M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $38.26M S-4/A · filed 2026-09-03 |
| 2025-03-31 | $46.71M S-4/A · filed 2026-09-03 |
| 2024-12-31 | $61.26M S-4/A · filed 2026-09-03 |
| 2024-09-30 | $72.72M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $90.56M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $104.88M 10-Q · filed 2025-08-12 |
| 2023-12-31 | $111.28M S-4/A · filed 2026-09-03 |
| 2023-09-30 | $126.28M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $150.41M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $170.35M 10-Q · filed 2024-08-08 |
| 2022-12-31 | $201.37M 10-K · filed 2025-03-04 |
| 2022-09-30 | $224.40M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $248.05M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $281.31M 10-Q · filed 2023-08-07 |
| 2021-12-31 | $318.66M 10-K · filed 2024-03-04 |
| 2021-09-30 | $362.23M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $402.27M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $441.50M 10-Q · filed 2022-08-04 |
| 2020-12-31 | $304.71M 10-K · filed 2023-03-06 |
| 2020-09-30 | $338.90M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $363.40M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $386.67M 10-Q · filed 2021-08-05 |
| 2019-12-31 | -$56.25M 10-K · filed 2022-03-03 |
| 2019-09-30 | -$44.15M 10-Q · filed 2020-11-10 |
| 2019-06-30 | -$32.93M 10-Q · filed 2020-11-10 |
| 2019-03-31 | -$19.60M 10-Q · filed 2020-08-13 |
| 2018-12-31 | -$12.17M 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |